Plasmodium falciparum multidrug resistance gene-1 polymorphisms in Northern Nigeria: implications for the continued use of artemether-lumefantrine in the region
- PMID: 33256739
- PMCID: PMC7708160
- DOI: 10.1186/s12936-020-03506-z
Plasmodium falciparum multidrug resistance gene-1 polymorphisms in Northern Nigeria: implications for the continued use of artemether-lumefantrine in the region
Abstract
Background: The analysis of single nucleotide polymorphism (SNPs) in drug-resistance associated genes is a commonly used strategy for the surveillance of anti-malarial drug resistance in populations of parasites. The present study was designed and performed to provide genetic epidemiological data of the prevalence of N86Y-Y184F-D1246Y SNPs in Plasmodium falciparum multidrug resistance 1 (pfmdr1) in the malaria hotspot of Northern Nigeria.
Methods: Plasmodium falciparum-positive blood samples on Whatman-3MM filter papers were collected from 750 symptomatic patients from four states (Kano, Kaduna, Yobe and Adamawa) in Northern Nigeria, and genotyped via BigDye (v3.1) terminator cycle sequencing for the presence of three SNPs in pfmdr1. SNPs in pfmdr1 were used to construct NYD, NYY, NFY, NFD, YYY, YYD, YFD and YFY haplotypes, and all data were analysed using Pearson Chi square and Fisher's exact (FE) tests.
Results: The prevalence of the pfmdr1 86Y allele was highest in Kaduna (12.50%, 2 = 10.50, P = 0.02), whilst the 184F allele was highest in Kano (73.10%, 2 = 13.20, P = 0.00), and the pfmdr1 1246Y allele was highest in Yobe (5.26%, 2 = 9.20, P = 0.03). The NFD haplotype had the highest prevalence of 69.81% in Kano (2 = 36.10, P = 0.00), followed by NYD with a prevalence of 49.00% in Adamawa, then YFD with prevalence of 11.46% in Kaduna. The YYY haplotype was not observed in any of the studied states.
Conclusion: The present study suggests that strains of P. falciparum with reduced sensitivity to the lumefantrine component of AL exist in Northern Nigeria and predominate in the North-West region.
Keywords: Anti-malarial drug resistance; Haplotypes; P. falciparum; Single nucleotide polymorphisms; pfmdr1.
Conflict of interest statement
The authors of this study have no competing interest to declare.
Figures




Similar articles
-
Spatio-temporal distribution of PfMDR1 polymorphism among uncomplicated Plasmodium falciparum malaria cases along international border of north east India.Infect Genet Evol. 2018 Sep;63:285-290. doi: 10.1016/j.meegid.2018.05.025. Epub 2018 May 26. Infect Genet Evol. 2018. PMID: 29842979
-
Clinical isolates of uncomplicated falciparum malaria from high and low malaria transmission areas show distinct pfcrt and pfmdr1 polymorphisms in western Ethiopia.Malar J. 2023 Jun 3;22(1):171. doi: 10.1186/s12936-023-04602-6. Malar J. 2023. PMID: 37270589 Free PMC article.
-
Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.Malar J. 2014 Jul 9;13:264. doi: 10.1186/1475-2875-13-264. Malar J. 2014. PMID: 25007802 Free PMC article.
-
Trends of Plasmodium falciparum molecular markers associated with resistance to artemisinins and reduced susceptibility to lumefantrine in Mainland Tanzania from 2016 to 2021.Malar J. 2024 Mar 9;23(1):71. doi: 10.1186/s12936-024-04896-0. Malar J. 2024. PMID: 38461239 Free PMC article.
-
Impact of treatment and re-treatment with artemether-lumefantrine and artesunate-amodiaquine on selection of Plasmodium falciparum multidrug resistance gene-1 polymorphisms in the Democratic Republic of Congo and Uganda.PLoS One. 2018 Feb 1;13(2):e0191922. doi: 10.1371/journal.pone.0191922. eCollection 2018. PLoS One. 2018. PMID: 29390014 Free PMC article. Clinical Trial.
Cited by
-
The structure of Plasmodium falciparum multidrug resistance protein 1 reveals an N-terminal regulatory domain.Proc Natl Acad Sci U S A. 2023 Aug 8;120(32):e2219905120. doi: 10.1073/pnas.2219905120. Epub 2023 Aug 1. Proc Natl Acad Sci U S A. 2023. PMID: 37527341 Free PMC article.
-
Two decades of molecular surveillance in Senegal reveal changes in known drug resistance mutations associated with historical drug use and seasonal malaria chemoprevention.medRxiv [Preprint]. 2023 Apr 26:2023.04.24.23288820. doi: 10.1101/2023.04.24.23288820. medRxiv. 2023. Update in: Malar J. 2024 Jul 9;23(1):205. doi: 10.1186/s12936-024-05024-8. PMID: 37163114 Free PMC article. Updated. Preprint.
-
Artemether-lumefantrine treatment failure of uncomplicated Plasmodium falciparum malaria in travellers coming from Angola and Mozambique.Int J Infect Dis. 2021 Sep;110:151-154. doi: 10.1016/j.ijid.2021.07.008. Epub 2021 Jul 7. Int J Infect Dis. 2021. PMID: 34242769 Free PMC article.
-
Genomic surveillance of malaria parasites in an indigenous community in the Peruvian Amazon.Sci Rep. 2024 Jul 15;14(1):16291. doi: 10.1038/s41598-024-66925-x. Sci Rep. 2024. PMID: 39009685 Free PMC article.
-
Temporal genomic analysis of Plasmodium falciparum reveals increased prevalence of mutations associated with delayed clearance following treatment with artemisinin-lumefantrine in Choma District, Southern Province, Zambia.medRxiv [Preprint]. 2024 Jun 6:2024.06.05.24308497. doi: 10.1101/2024.06.05.24308497. medRxiv. 2024. PMID: 38883763 Free PMC article. Preprint.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources